Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 1,319,000 | 1,373,900 | 1,341,200 | 1,329,700 | 1,310,200 |
| Cost of Goods | 253,800 | 269,400 | 299,300 | 309,500 | 311,700 |
| Gross Profit | 1,065,200 | 1,104,500 | 1,041,900 | 1,020,200 | 998,500 |
| Operating Expenses | 663,600 | 645,400 | 603,400 | 646,300 | 608,900 |
| Operating Income | 402,400 | 459,500 | 438,800 | 374,400 | 390,300 |
| Other Income | 4,900 | 5,200 | -2,700 | 1,900 | 600 |
| Pre-tax Income | 407,300 | 464,700 | 436,100 | 376,300 | 390,900 |
| Income Tax | 63,800 | 58,300 | 62,500 | 41,000 | 50,800 |
| Net Income Continuous | 343,500 | 406,400 | 373,600 | 335,300 | 340,100 |
| Net Income | $343,500 | $406,400 | $373,600 | $335,300 | $340,100 |
| EPS Basic Total Ops | 0.55 | 0.65 | 0.60 | 0.53 | 0.55 |
| EPS Basic Continuous Ops | 0.55 | 0.65 | 0.60 | 0.54 | 0.55 |
| EPS Diluted Total Ops | 0.55 | 0.65 | 0.59 | 0.52 | 0.54 |
| EPS Diluted Continuous Ops | 0.55 | 0.65 | 0.59 | 0.53 | 0.54 |
| EPS Diluted Before Non-Recurring Items | 0.61 | 0.63 | 0.60 | N/A | N/A |
| EBITDA(a) | $437,800 | $493,600 | $473,500 | $407,400 | $423,900 |